Inflammation is both good news and bad news. On the plus side, it is a vital part of the immune system's response to injury and infection. It tells the body to repair damaged tissue or fight off an infection. Anyone who has sprained an ankle, bruised an arm or fought off a cold knows the positive benefits of inflammation.
However, when the inflammatory response goes on too long or shows up where it's not needed, it can become problematic. This type of inflammation—called chronic low-level inflammation—has been linked to heart disease, certain types of cancer, cardio-respiratory disease, diabetes and obesity.
How do you know if you have chronic low-level inflammation or are at risk for developing it—and what can you do about it? In an engaging, evidence-based presentation, Sally Duplantier will share relevant research related to the causes of low-level chronic inflammation. She will discuss how lifestyle choices such as nutrition, movement, sleep and stress management can protect us from this type of "inflammation gone awry." You will walk away with an action plan of one to two changes you can make in your daily life to minimize your risk of low-level chronic inflammation.
Sally is the founder of Zing, a company that helps people 50 and older improve their health span—the number of years in which they are healthy, active and mentally sharp. She has a certificate in Nutrition Science from Stanford Medical School and is studying the science of aging at USC, where she is working on a Masters in Gerontology. Sally has received numerous awards for her entrepreneurial expertise, including Woman Entrepreneur of the Year (Inc. and Ernst & Young) and Top 25 Women Making Business History (National Association of Women Business Owners). She believes that "age does not define us; we define how we want to age."
Daytime Adult Learning and Culture Programs are made possible in part by the John R. Schwabacher Family as well as a grant from the Maimonides Fund at the Jewish Community Federation & Endowment Fund. We are grateful for their generous support.
Tuesday, February 2, 2021